We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Artificial Heart Driver Helps Patients Stay Mobile

By HospiMedica International staff writers
Posted on 07 Apr 2010
A portable artificial heart driver could soon offer "bridge to transplant” patients the option of being discharged from the hospital while awaiting an appropriate donor heart. More...


The Freedom driver system is a portable driver designed to power the SynCardia (Tucson, AZ, USA) CardioWest Total Artificial Heart, for use at their home, in their communities, and at step-down facilities. The Freedom driver weighs six kilograms, including two onboard lithium ion batteries and a power adaptor. It can be conveniently carried by the patient in a proprietary backpack or shoulder bag. The Freedom driver uses a "dark cockpit" design, meaning the driver only flashes a light and sounds an alarm when something requires the user's attention. No onsite repair or inventory of parts is required by the hospital, and service for the driver will only be by replacement via express delivery.

The Freedom driver system has received the European Community (CE marking) approval, and has concomitantly received conditional approval from the U.S. Food & Drug Administration (FDA) to conduct an investigational device exemption (IDE) clinical study of the system. The trial is expected to enroll 60 patients and will follow them until transplant, 90 days after discharge, or death.

"The new Freedom driver is the first wearable portable driver for powering the Total Artificial Heart,” said Rodger Ford, president and CEO of SynCardia. "It will allow stable European Total Artificial Heart patients to enjoy a quality lifestyle at home and in their communities while they wait for a matching donor heart.”

"While waiting for a transplant, patients can stay in the hospital for several months and in some rare cases, more than a year,” said Stephen Clayson, M.D., of the Utah Artificial Heart Program at Intermountain Medical Center (Murray, UT, USA). "We are pleased to initiate the IDE clinical study and evaluate the use of the Freedom driver to power the Total Artificial Heart. If the IDE clinical study of the Freedom driver is successful, patients will be able to sleep in their own bed, spend time with their families, and be more self-sufficient.”

Related Links:
SynCardia
Intermountain Medical Center


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gas Analyzer
GE SAM
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.